Orphan drug designation, or ODD, is valuable on both a humanitarian and a profitability basis. And this company is seeing shares rally following news that it was granted the designation for the...

To read the full story on AllPennyStocks.com, click here.

Cardiol Therapeutics (NASDAQ:CRDL)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 Cardiol Therapeutics 차트를 더 보려면 여기를 클릭.
Cardiol Therapeutics (NASDAQ:CRDL)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 Cardiol Therapeutics 차트를 더 보려면 여기를 클릭.